SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-143642
Filing Date
2019-05-10
Accepted
2019-05-10 07:52:05
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d738207d10q.htm 10-Q 324331
2 EX-31.1 d738207dex311.htm EX-31.1 11008
3 EX-31.2 d738207dex312.htm EX-31.2 11002
4 EX-32.1 d738207dex321.htm EX-32.1 4829
5 EX-32.2 d738207dex322.htm EX-32.2 4822
  Complete submission text file 0001193125-19-143642.txt   3456441

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20190331.xml EX-101.INS 827319
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20190331.xsd EX-101.SCH 33138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20190331_cal.xml EX-101.CAL 20731
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20190331_def.xml EX-101.DEF 224636
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20190331_lab.xml EX-101.LAB 273535
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20190331_pre.xml EX-101.PRE 255725
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 19812879
SIC: 2834 Pharmaceutical Preparations